Death Of Covid Patients Due To Non-Supply Of Oxygen ‘Criminal Act’: Allahabad HC
Mumbai: The Allahabad High Court on Tuesday took cognizance of the increasing fatal cases due to the second wave of rising coronavirus, and said that COVID-19 patients died due to lack of oxygen “is a criminal act and nothing less than genocide.”
Also Read: TN: 13 Patients Die Overnight At Govt Hosp In Chengalpet, Due To Oxygen Shortage
The high court remarked amid a severe shortage of medical oxygen in hospitals across the country due to a dangerous spike in COVID-19 infection.
Also Read: 5 COVID-19 Patients Die At Roorkee Hospital Due To Oxygen Shortage
“We are seeing that the death of COVID patients for non-treatment of oxygen in hospitals is a criminal act and is nothing short of a genocide for those who have been entrusted the task to ensure continuous procurement and supply chain of the liquid medical oxygen,” the order by a bench of Justice Ajit Kumar and Justice Siddhartha Varma read.
Also Read: Karnataka: 5 COVID-19 Patients Die In Hubballi Hospital, Kin Allege Oxygen Shortage
The High Court said that reports of hoarding and harassment of oxygen cylinders were given to poor citizens, who are begging for oxygen cylinders to save the lives of their loved ones, the district administration as well as the police administration, viral on social media.
“The news was also viralled that five patients had died in ICU of a new trauma centre of Medical College, Meerut on Sunday last. Similarly, reports were also going viral that a Surya Hospital, Gomti Nagar, Lucknow and another private hospital Meerut had taken COVID patients for treatment by their hands only for the reason that oxygen was not supplied even after demand. We find these news items showing a quite contrary picture to one claimed by the Government that there was sufficient supply of oxygen,” the bench pointed out.
India on Tuesday recorded more than 3,80,000 new coronavirus cases and a record high death toll of 3,783 in the past 24 hours.
(With Agency Inputs)
Follow us on Twitter, Instagram, and like us on Facebook for the latest updates and interesting stories.
